Methods of Treatment Using Antibodies to Neutrokine-alpha
    31.
    发明申请
    Methods of Treatment Using Antibodies to Neutrokine-alpha 审中-公开
    使用抗坏血酸α的抗体治疗方法

    公开(公告)号:US20060193859A1

    公开(公告)日:2006-08-31

    申请号:US11382837

    申请日:2006-05-11

    IPC分类号: A61K39/395 C07K16/24

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Methods of treatment of immune system related disorders using Neutrokine-alpha
    32.
    发明授权
    Methods of treatment of immune system related disorders using Neutrokine-alpha 有权
    使用Neutrokine-α治疗免疫系统相关疾病的方法

    公开(公告)号:US06881401B1

    公开(公告)日:2005-04-19

    申请号:US09589285

    申请日:2000-06-08

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Diagnostic methods using antibodies to Neutrokine-alpha
    34.
    发明授权
    Diagnostic methods using antibodies to Neutrokine-alpha 有权
    使用Neutrokine-α抗体的诊断方法

    公开(公告)号:US06562579B1

    公开(公告)日:2003-05-13

    申请号:US09588947

    申请日:2000-06-08

    IPC分类号: G01N3353

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。

    Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha
    35.
    发明授权
    Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha 有权
    使用Neutrokine-α抗体抑制B淋巴细胞的方法

    公开(公告)号:US08071092B1

    公开(公告)日:2011-12-06

    申请号:US09589288

    申请日:2000-06-08

    摘要: The present invention relates to a novel Neutrokine-alpha, and a splice variant thereof designated Neutrokine-alphaSV, polynucleotides and polypeptides which are members of the TNF family. In particular, isolated nucleic acid molecules are provided encoding the human Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Neutrokine-alpha and/or Neutrokine-alphaSV activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及一种新的Neutrokine-α及其剪接变体,其命名为Neutrokine-αSV,作为TNF家族成员的多核苷酸和多肽。 特别地,提供编码人Neutrokine-α和/或中枢神经素-αSV多肽的分离的核酸分子,包括细胞外结构域的可溶形式。 还提供了中和型α和/或中枢神经素αSV多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明进一步涉及用于鉴定中和性α和/或中枢神经素αSV活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测免疫系统相关疾病的诊断方法和用于治疗免疫系统相关疾病的治疗方法。